Loading organizations...
Key people at AssistRx.
AssistRx was founded in 2009 by Jacques Fu (CTO, Tech Co-founder).
Based in Orlando, Florida, AssistRx is a healthcare technology company that provides patient access and support solutions for specialty pharmaceuticals. The company operates a business-to-business platform that connects healthcare providers, patients, life sciences companies, and pharmacies to streamline prescribing, insurance coverage, and medication onboarding workflows. Operating with a workforce of over 500 employees, the organization generates approximately $111.5 million in revenue while supporting millions of patients and hundreds of thousands of healthcare providers annually. AssistRx serves more than 40 life sciences organizations, including nine of the ten largest biotechnology companies, and has secured strategic investments from institutional backers like Novo Holdings and Welsh, Carson, Anderson & Stowe. The firm has recently expanded its product portfolio by integrating AllazoHealth and launching services in partnership with GoodRx. AssistRx was founded in 2009 by Jeff Spafford and Edward Hensley.
AssistRx is a healthcare technology company that builds an interoperable platform connecting patients, healthcare providers, and life sciences organizations to streamline access to specialty therapies, addressing challenges in access, affordability, and adherence.[1][2][3] It serves life sciences companies (including nine of the top 10 largest biotech firms), healthcare providers, specialty pharmacies, and patients by offering solutions like iAssist (ePrescribing and eEnrollment), Patient Solutions, CoAssist (EHR-integrated therapy fulfillment), and AllazoHealth (AI-driven patient engagement), powered by a blend of advanced technology and pharmaceutical expertise.[1][3][4] The company solves complex hurdles in specialty pharmaceutical distribution, such as therapy initiation delays, prior authorizations, and adherence, enabling faster patient uptake, real-time visibility, and improved outcomes—processing millions of transactions, supporting millions of patients, and serving thousands of healthcare providers annually.[3]
With 1,435 US employees across facilities in Florida, Kansas, and Iowa, AssistRx demonstrates strong growth momentum, expanding services like non-commercial pharmacy, field nurse networks, and GoodRx integration while maintaining a patient-first culture recognized as a Top Workplace.[2][4]
AssistRx was founded in 2009 by Jeff Spafford and Edward Hensley, both with extensive experience in specialty pharmaceutical services, to simplify patient access to therapies through technology and expertise.[4][5] The idea emerged from recognizing inefficiencies in the specialty pharma ecosystem, leading to the launch of the core AssistRx Platform that year.[4]
Key milestones include the 2011 debut of iAssist and Directive Analytics; 2013 expansion into Patient Solutions in Orlando, FL; 2018 growth to Overland Park, KS, with a nationwide field nurse network; 2019 additions of non-commercial pharmacy, ReMy Health integrations, and a Des Moines innovation office; 2022-2023 office expansions; and 2024 launch of GoodRx Prescription Services.[4] Today, under CEO Lee Cooper, it has evolved into a scalable provider for over 40 life sciences clients, blending mature stability with entrepreneurial agility.[4][5][7]
AssistRx rides the wave of digital health transformation in specialty pharmaceuticals, where rising demand for high-cost therapies (e.g., oncology, rare diseases) meets regulatory and reimbursement complexities, amplified by AI, EHR integration, and value-based care trends.[1][6] Timing is ideal amid post-pandemic shifts to telehealth, real-time data, and patient-centric models, with market forces like pharmacy benefit managers' scrutiny and biotech growth favoring interoperable platforms that cut delays and boost adherence.[3][8]
It influences the ecosystem by enabling life sciences to scale patient support independently, reducing reliance on fragmented vendors, while empowering providers with ePrescribing and HCPs with seamless workflows—ultimately driving industry-wide efficiency in a $100B+ specialty drug market.[1][4][6]
AssistRx is poised for continued expansion by leveraging AI enhancements (e.g., via AllazoHealth), pharmacy integrations like GoodRx, and potential M&A in digital health to capture more of the specialty pharma support market.[1][4] Trends like personalized medicine, real-world evidence demands, and regulatory pushes for transparency will shape its path, amplifying its role as a neutral, scalable hub amid consolidating competitors.
As biotech therapies proliferate, AssistRx's tech-talent fusion positions it to transform even more lives through frictionless access, solidifying its status as the go-to partner for therapy journeys that start efficiently and end in better health.
AssistRx was founded in 2009 by Jacques Fu (CTO, Tech Co-founder).
Key people at AssistRx.
